Detalles de la búsqueda
1.
Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial.
J Thromb Thrombolysis;
2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762708
2.
COVID-19 Vaccination and Cardiopulmonary Events After Acute Coronary Syndromes: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open;
7(5): e2413946, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38814645
3.
Prospective, randomized, controlled trial assessing the effects of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome due to community-acquired pneumonia (STAMINA trial): protocol and statistical analysis plan.
Crit Care Sci;
36: e20240210en, 2024.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-38775567
4.
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.
JCO Glob Oncol;
10: e2300484, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38603658
5.
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
Crit Care Sci;
35(3): 256-265, 2023.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-38133155
6.
Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial.
Sci Rep;
13(1): 18405, 2023 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37891178
7.
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study / Dapagliflozina em pacientes com doença crítica: justificativa e desenho do estudo DEFENDER
Crit. Care Sci;
35(3): 256-265, July-Sept. 2023. tab, graf
Artículo
en Inglés
| LILACS-Express
| ID: biblio-1528466
8.
The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study.
Am Heart J;
264: 97-105, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37330162
9.
Longitudinal study comparing IgG antibodies induced by heterologous prime-boost COVID-19 vaccine.
J Med Virol;
95(1): e28379, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36478244
10.
Efeitos da solução balanceada em desfechos de curto prazo em pacientes com traumatismo craniencefálico: uma análise secundária do ensaio clínico randomizado BaSICS / Effects of balanced solution on short-term outcomes in traumatic brain injury patients: a secondary analysis of the BaSICS randomized trial
Rev. bras. ter. intensiva;
34(4): 410-417, out.-dez. 2022. tab, graf
Artículo
en Portugués
| LILACS-Express
| ID: biblio-1423681
11.
Antivirals for adult patients hospitalized with SARS-CoV-2 infection: A randomized, Phase II/III, multicenter, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX - REVOLUTIOn: protocol and statistical analysis plan. / Antivirais para pacientes adultos hospitalizados com infecção por SARS-CoV-2: Um estudo de Fase II/III, randomizado, multicêntrico, controlado por placebo, adaptativo, com múltiplos braços e estágios. COALITION COVID-19 BRAZIL IX - REVOLUTIOn: protocolo e plano de análise estatística.
Rev Bras Ter Intensiva;
34(1): 44-55, 2022.
Artículo
en Portugués, Inglés
| MEDLINE | ID: mdl-35766657
12.
The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial.
Trials;
23(1): 255, 2022 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379306
13.
Antivirais para pacientes adultos hospitalizados com infecção por SARS-CoV-2: Um estudo de Fase II/III, randomizado, multicêntrico, controlado por placebo, adaptativo, com múltiplos braços e estágios. COALITION COVID-19 BRAZIL IX - REVOLUTIOn: protocolo e plano de análise estatística / Antivirals for adult patients hospitalized with SARS-CoV-2 infection: A randomized, Phase II/III, multicenter, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX - REVOLUTIOn: protocol and statistical analysis plan
Rev. bras. ter. intensiva;
34(1): 44-55, jan.-mar. 2022. tab, graf
Artículo
en Portugués
| LILACS-Express
| ID: biblio-1388049
14.
Effects of balanced solution on short-term outcomes in traumatic brain injury patients: a secondary analysis of the BaSICS randomized trial. / Efeitos da solução balanceada em desfechos de curto prazo em pacientes com traumatismo craniencefálico: uma análise secundária do ensaio clínico randomizado BaSICS.
Rev Bras Ter Intensiva;
34(4): 410-417, 2022.
Artículo
en Portugués, Inglés
| MEDLINE | ID: mdl-36888820
15.
Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial.
JAMA;
326(21): 2161-2171, 2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874419
16.
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
Lancet;
397(10291): 2253-2263, 2021 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097856
17.
Statistical analysis plan for the Balanced Solution versus Saline in Intensive Care Study (BaSICS). / Plano de análise estatística para o estudo Balanced Solution versus Saline in Intensive Care Study (BaSICS).
Rev Bras Ter Intensiva;
32(4): 493-505, 2020.
Artículo
en Portugués, Inglés
| MEDLINE | ID: mdl-33263702
18.
Plano de análise estatística para o estudo Balanced Solution versus Saline in Intensive Care Study (BaSICS) / Statistical analysis plan for the Balanced Solution versus Saline in Intensive Care Study (BaSICS)
Rev. bras. ter. intensiva;
32(4): 493-505, out.-dez. 2020. tab, graf
Artículo
en Inglés, Portugués
| LILACS | ID: biblio-1156239
19.
COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial. / Síndrome do desconforto respiratório agudo associada à COVID-19 tratada com DEXametasona (CoDEX): delineamento e justificativa de um estudo randomizado.
Rev Bras Ter Intensiva;
32(3): 354-362, 2020.
Artículo
en Portugués, Inglés
| MEDLINE | ID: mdl-33053024
20.
Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS). / Justificativa e delineamento do estudo "Tocilizumabe em pacientes com COVID-19 moderado a grave: estudo aberto, multicêntrico, randomizado, controlado" (TOCIBRAS).
Rev Bras Ter Intensiva;
32(3): 337-347, 2020.
Artículo
en Portugués, Inglés
| MEDLINE | ID: mdl-32965395